ADM Purchases Deerland Probiotics & Enzymes

The transaction is expected to be completed in the coming weeks, at which point Deerland’s approximately 320 employees will transfer to ADM.

Image courtesy of ADM.

Chicago, IL—ADM has purchased Deerland Probiotics & Enzymes, according to a press release.

“The microbiome represents one of ADM’s six strategic growth platforms, and with global demand for health and wellness products estimated at more than $775 billion, today’s investment represents a significant step forward for ADM,” said ADM Chairman and CEO Juan Luciano. “Deerland Probiotics & Enzymes is a leader in probiotic, prebiotic and enzyme technology, with global sales and manufacturing in the U.S. and Europe, and is a perfect fit for our growing portfolio of functional ingredients and solutions for health-conscious consumers. We expect the addition of the Deerland capabilities and portfolio to deliver synergies for our Health & Wellness business and support growth across our Nutrition business unit.”

Deerland provides probiotic, prebiotic, and enzyme technology, including 12 branded product lines targeting digestive health, immune health, women’s health, food intolerance, cellular repair, sports nutrition, and cardiovascular health. Products include spore probiotics, which offer stability for a wider use in food and beverage applications. The company has five manufacturing facilities, one fermentation facility, and eight R&D and quality control laboratories globally.

Related: ADM Reports Eighth Consecutive Quarter of Profit Growth
Study Proves Survivability of Deerland’s DE111
ADM, LG Chem Agree to Multiple Joint Ventures

“The hand-in-glove fit of Deerland’s vast portfolio of branded technologies, clinical studies and world-class dosage form production capabilities combined with ADM’s Health and Wellness solutions is strong and unparalleled, allowing us to provide our dietary supplement, food/beverage and companion animal customers with a much broader array of products and capabilities,” said Scott Ravech, Deerland Probiotics & Enzymes CEO. “The Deerland team could not be more excited at the opportunity to be a part of the ADM family.”

The acquisition is another step towards ADM’s goal of building a full-scale global health & wellness business. With Deerland’s revenue, annual revenue for ADM’s Health & Wellness segment will exceed $500 million.

The transaction is expected to be completed in the coming weeks, at which point Deerland’s approximately 320 employees will transfer to ADM.